AGOMELATINE IN CHILDREN AND ADOLESCENTS WITH MODERATE TO SEVERE MAJOR DEPRESSIVE DISORDER: 2-YEAR OPEN-LABEL EXTENSION STUDY

被引：0
|
作者：
Falissard, B. [1 ]
Buitelaar, J. K. [2 ,3 ]
Fegert, J. M. [4 ]
Penelaud, P. F. [5 ]
Marx, U. [6 ]
Picarel-Blanchot, F. [7 ]
Arango, C. [8 ]
机构：
[1] Sante Mentale & Sante Publ, Ctr Rech Epidemiol & Sante Populat, INSERM, U018, Paris, France
[2] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Dept Cognit Neurosci, Med Ctr, Nijmegen, Netherlands
[3] Karakter Child & Adolescent Psychiat Univ Ctr, Nijmegen, Netherlands
[4] Univ Hosp Ulm, Dept Child & Adolescent Psychiat Psychotherapy, Ulm, Germany
[5] Inst Rech Int Servier, Ctr Therapeut Innovat, Suresnes, France
[6] Servier Forsch & Pharma, Munich, Germany
[7] Global Med & Patient Affairs GMPA, Internal Med & Neuropsychiat, Suresnes, France
[8] Univ Complutense, Hosp Gen Univ Gregorio Maranon, Inst Psychiat & Mental Hlth, IiSGM,Sch Med, Madrid, Spain
来源：
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY | 2023年 / 57卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：138 / 138
页数：1
相关论文
共 50 条
  • [1] Agomelatine in pediatric patients with moderate to severe major depressive disorder: an open-label extension study
    Arango, Celso
    Fegert, Joerg M.
    Picarel-Blanchot, Francoise
    Marx, Ute
    Truffaut-Chalet, Lucie
    Penelaud, Pierre-Francois
    Buitelaar, Jan
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2024,
  • [2] MAJOR DEPRESSIVE DISORDER, ANHEDONIA, AND AGOMELATINE: AN OPEN-LABEL STUDY
    Martinotti, G.
    Di Iorio, G.
    Guglielmo, R.
    De Berardis, D.
    Janiri, L.
    Di Giannantonio, M.
    EUROPEAN PSYCHIATRY, 2011, 26
  • [3] MAJOR DEPRESSIVE DISORDER, ANHEDONIA AND AGOMELATINE: AN OPEN-LABEL STUDY
    di Giannantonio, M.
    Di Iorio, G.
    Guglielmo, R.
    De Berardis, D.
    Conti, C. M.
    Acciavatti, T.
    Cornelio, M.
    Martinotti, G.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2011, 25 (01): : 109 - 114
  • [4] Major depressive disorder, sleep EEG and agomelatine: an open-label study
    Salva, Maria-Antonia Quera
    Vanier, Bernard
    Laredo, Judith
    Hartley, Sarah
    Chapotot, Florian
    Moulin, Catherine
    Lofaso, Frederic
    Guilleminault, Christian
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2007, 10 (05): : 691 - 696
  • [5] EFFICACY OF LURASIDONE IN CHILDREN AND ADOLESCENTS WITH BIPOLAR DEPRESSION: RESULTS FROM A 2-YEAR OPEN-LABEL EXTENSION STUDY
    Delbello, Melissa P.
    Goldman, Robert S.
    Tocco, Michael
    Pikalov, Andrei A.
    Loebel, Antony
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2019, 58 (10): : S231 - S231
  • [6] Five-year open-label extension study of safety and efficacy of etanercept in children and adolescents with moderate to severe plaque psoriasis
    Paller, Amy S.
    Siegfried, Elaine C.
    Pariser, David M.
    Rice, Kara Creamer
    Trivedi, Mona
    Iles, Jan
    Collier, David H.
    Kricorian, Greg
    Langley, Richard G.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB251 - AB251
  • [7] Safety and effectiveness of lurasidone in adolescents with schizophrenia: results of a 2-year, open-label extension study
    Correll, Christoph U.
    Findling, Robert L.
    Tocco, Michael
    Pikalov, Andrei
    Deng, Ling
    Goldman, Robert
    CNS SPECTRUMS, 2022, 27 (01) : 118 - 128
  • [8] EFFECTIVENESS AND SAFETY OF LURASIDONE IN ADOLESCENTS WITH SCHIZOPHRENIA: ANALYSIS OF A 2-YEAR, OPEN-LABEL EXTENSION STUDY
    Correll, C. U.
    Tocco, M.
    Pikalov, A.
    Goldman, R.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2021, 55 (1_SUPPL): : 103 - 104
  • [9] Efficacy and safety of lurasidone in adolescents with schizophrenia: Results of a 2-year, open-label extension study
    Goldman, R.
    Correll, C.
    Tocco, M.
    Pikalov, A.
    Deng, L.
    Loebel, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S88 - S89
  • [10] Efficacy and safety of lurasidone in adolescents with schizophrenia: analysis of a 2-year, open-label extension study
    Goldman, R.
    Tocco, M.
    Pikalov, A.
    Ling, D.
    Loebel, A.
    EUROPEAN PSYCHIATRY, 2019, 56 : S275 - S276
12345